Literature DB >> 24407358

The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation.

Chengfu Yuan1, Lei Wang2, Liang Zhou1, Zheng Fu1.   

Abstract

Polo-like kinase 1 (PLK1) plays crucial roles in multiple stages of cell division. Our previous studies suggest that global transcriptional regulation by PLK1 may contribute to its multiple functions. PLK1 depletion is associated with a decrease in cell viability and the induction of apoptosis; however, the underlying mechanisms are not completely understood. Here, we report that forkhead box protein O1 (FOXO1) is a novel physiological substrate of PLK1. FOXO1 is at the interface of crucial cellular processes, orchestrating programs of gene expression that regulate apoptosis, cell cycle progression, and oxidative-stress resistance. PLK1 interacts with and phosphorylates FOXO1, mainly at the G 2/M phase of the cell cycle. PLK1-mediated phosphorylation leads to the impairment of FOXO1's transcriptional activity in an Akt-independent manner. By immunofluorescence staining and subcellular fractionation, we demonstrate that PLK1-induced FOXO1 phosphorylation causes its nuclear exclusion. Furthermore, PLK1-mediated phosphorylation of FOXO1 negatively regulates its pro-apoptotic function and abrogates its ability to delay entry into and progression through G 2/M transition. Therefore, our results suggest that PLK1 abrogates the inhibitory effects of FOXO1 on cell growth and survival to ensure timely cell cycle progression. This study not only reveals a novel and major regulatory mechanism of FOXO1 at the late phases of the cell cycle, but also provides new insight into the molecular mechanisms by which PLK1 inhibition leads to growth arrest and cell death.

Entities:  

Keywords:  FOXO1; PLK1; apoptosis; cell division; nuclear-cytoplasmic shuttling; phosphorylation; regulation; transcription factor

Mesh:

Substances:

Year:  2014        PMID: 24407358      PMCID: PMC3979917          DOI: 10.4161/cc.27727

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  Direct control of the Forkhead transcription factor AFX by protein kinase B.

Authors:  G J Kops; N D de Ruiter; A M De Vries-Smits; D R Powell; J L Bos; B M Burgering
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

2.  Negative regulation of the forkhead transcription factor FKHR by Akt.

Authors:  E D Tang; G Nuñez; F G Barr; K L Guan
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

3.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

Review 4.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

5.  On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.

Authors:  K E Mundt; R M Golsteyn; H A Lane; E A Nigg
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

6.  Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.

Authors:  G Rena; S Guo; S C Cichy; T G Unterman; P Cohen
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

7.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

Review 8.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

9.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.

Authors:  W H Biggs; J Meisenhelder; T Hunter; W K Cavenee; K C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

10.  Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells.

Authors:  Haojie Huang; David C Muddiman; Donald J Tindall
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

View more
  15 in total

1.  Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.

Authors:  Peng Xia; Jingrui Chen; Yuening Liu; Maya Fletcher; Brian C Jensen; Zhaokang Cheng
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

2.  AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.

Authors:  Chun-Wu Pan; Xin Jin; Yu Zhao; Yunqian Pan; Jing Yang; R Jeffrey Karnes; Jun Zhang; Liguo Wang; Haojie Huang
Journal:  EMBO J       Date:  2017-03-09       Impact factor: 11.598

3.  JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1.

Authors:  Poornima Ramkumar; Clement M Lee; Annie Moradian; Michael J Sweredoski; Sonja Hess; Andrew D Sharrocks; Dale S Haines; E Premkumar Reddy
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

4.  SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.

Authors:  Donghua Wen; Jianguo Wu; Lei Wang; Zheng Fu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

5.  Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.

Authors:  Carsten Berges; Manik Chatterjee; Max S Topp; Hermann Einsele
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

6.  Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.

Authors:  Renata Ferrarotto; Ruchitha Goonatilake; Suk Young Yoo; Pan Tong; Uma Giri; Shaohua Peng; John Minna; Luc Girard; Yuehong Wang; Liguang Wang; Lerong Li; Lixia Diao; David H Peng; Don L Gibbons; Bonnie S Glisson; John V Heymach; Jing Wang; Lauren A Byers; Faye M Johnson
Journal:  Clin Cancer Res       Date:  2015-11-23       Impact factor: 12.531

Review 7.  Extinguishing the Embers: Targeting AML Metabolism.

Authors:  Rachel Culp-Hill; Angelo D'Alessandro; Eric M Pietras
Journal:  Trends Mol Med       Date:  2020-10-26       Impact factor: 11.951

8.  Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling.

Authors:  Jianguo Wu; Andrei I Ivanov; Paul B Fisher; Zheng Fu
Journal:  Elife       Date:  2016-03-22       Impact factor: 8.140

9.  Mass spectrometry-based quantification of the cellular response to ultraviolet radiation in HeLa cells.

Authors:  Hong Xu; Xuanyi Chen; Nanjiao Ying; Meixia Wang; Xiaoli Xu; Rongyi Shi; Yuejin Hua
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

10.  The impact of Mir-9 regulation in normal and malignant hematopoiesis.

Authors:  Abbas Khosravi; Shaban Alizadeh; Arsalan Jalili; Reza Shirzad; Najmaldin Saki
Journal:  Oncol Rev       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.